Medicating schizophrenia : a history
著者
書誌事項
Medicating schizophrenia : a history
Rutgers Unviversity Press, 1999
- : pbk
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Traditionally, schizophrenia has been one of the most misunderstood and difficult-to-treat mental illnesses. Prior to the creation of antipsychotic medications in the 1950s, the only available treatments were frequently dangerous, and of questionable efficacy. By the 1960s, new medications had virtually replaced the old therapies, creating a revolution in the treatment of mental illness. It was thought that people with schizophrenia would be able to live independently in their communities, returning to hospitals only briefly to have a medication regimen adjusted or re-insituted. This period of hope did not last as patients began to experience disturbing side-effects and the medications were found to be less effecive than originally thought. What led doctors to embrace the new drug treatments so quickly? Did a rush to de-institutionalization give doctors, patients and the general public false and dangerous hopes? Could this happen today? Sheldon Gelman looks at the manner in which psychiatrists have evaluated, interpreted and prescribed antipsychotic drugs since their inception from the 1950s to the present.
Gelman argues that hospitals were being emptied not because patients were "cured", but rather because of the changing ways society came to view disease, drugs and scientific remedies.
「Nielsen BookData」 より